(Q53130474)

11 May 2018

title

Does occasional cannabis use impact anxiety and depression treatment outcomes?: Results from a randomized effectiveness trial. (English)

1 reference

11 May 2018

7

Peter Roy-Byrne

1 reference

11 May 2018

Michelle Craske

5

Michelle Craske

1 reference

11 May 2018

Murray B. Stein

3

Murray B Stein

1 reference

11 May 2018

Cathy D Sherbourne

4

Cathy Sherbourne

1 reference

11 May 2018

Joan Russo

2

Joan Russo

1 reference

11 May 2018

author name string

Jonathan B Bricker

1

1 reference

11 May 2018

Trevor J Schraufnagel

6

1 reference

11 May 2018

publication date

1 January 2007

1 reference

11 May 2018

published in

Depression and Anxiety

1 reference

11 May 2018

volume

24

1 reference

11 May 2018

issue

6

1 reference

11 May 2018

page(s)

392-398

1 reference

11 May 2018

Development of a brief diagnostic screen for panic disorder in primary care

cites work

1 reference

Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence

21 January 2018

1 reference

7 January 2021

Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial

1 reference

7 January 2021

An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults.

1 reference

7 January 2021

Marijuana use and the risk of Major Depressive Episode. Epidemiological evidence from the United States National Comorbidity Survey

1 reference

7 January 2021

Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: a review

1 reference

7 January 2021

Treating panic disorder in primary care: a collaborative care intervention

1 reference

7 January 2021

Comorbid cannabis use and panic disorder: short term and long term follow-up study

1 reference

7 January 2021

Cannabis dependence and withdrawal

1 reference

7 January 2021

Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D).

1 reference

7 January 2021

MIXREG: a computer program for mixed-effects regression analysis with autocorrelated errors.

1 reference

7 January 2021

Relationship between substance abuse and panic attacks

1 reference

7 January 2021

Major depressive disorder, suicidal ideation, and suicide attempt in twins discordant for cannabis dependence and early-onset cannabis use.

1 reference

7 January 2021

Brief standard self-rating for phobic patients

1 reference

7 January 2021

In search of mixed anxiety-depressive disorder: a primary care study

1 reference

7 January 2021

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

1 reference

7 January 2021

Fear of physical sensations and trait anxiety as mediators of the response to hyperventilation in nonclinical subjects.

1 reference

7 January 2021

Comorbidity: cannabis and complexity.

1 reference

7 January 2021

A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder

1 reference

7 January 2021

Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking

1 reference

7 January 2021

Pharmacotherapy of panic disorder: proposed guidelines for the family physician.

1 reference

7 January 2021

Anxiety sensitivity, anxiety frequency and the prediction of fearfulness

1 reference

7 January 2021

Fluoxetine in drug-dependent delinquents with major depression: an open trial.

1 reference

7 January 2021

The spectrum of substance use in mood and anxiety disorders

1 reference

7 January 2021

Predictors of response in generalized social phobia: effect of age of onset

1 reference

7 January 2021

The fear questionnaire. Some data on validity, reliability and layout

1 reference

7 January 2021

Identifiers

DOI

10.1002/DA.20248

1 reference

11 May 2018

PubMed ID

17096386

1 reference

11 May 2018